We proposed that ABCA6-43162-AT and PLIN5-46808-AT are regulated by YBX3 via the pathway of primary bile acid biosynthesis, and this regulatory relationship can lead to a poor prognosis and clinical outcome in the progression of HCC. Here, YBX3 is linked to hepatocellular carcinoma.